News
WXXWY
3.620
-2.43%
-0.090
Weekly Report: what happened at WXXWY last week (0429-0503)?
Weekly Report · 2d ago
Weekly Report: what happened at WXXWY last week (0422-0426)?
Weekly Report · 04/29 11:35
Artisan Developing World Fund Q1 2024 Commentary
Artisan Developing World Fund returned 11.09% for the quarter ended March 31, 2024, versus 2.37% for MSCI Emerging Markets Index. Top contributors to performance included graphics semiconductor company Nvidia, Indian online travel company MakeMyTrip. Taiwan was a standout emerging market during the quarter. Emerging currencies declined as rate cut expectations were pushed out.
Seeking Alpha · 04/25 07:00
WuXi Biologics: Staying On The Sidelines
WuXi Biologics (Cayman) Inc. Stock is rated as a Hold. The market's opinion of the company's 2024 financial prospects is negative. The company's top line growth is expected to slow to 7.6% in 2024. The interest rate environment and geopolitical risk factors are negative for the company.
Seeking Alpha · 04/24 19:27
Weekly Report: what happened at WXXWY last week (0415-0419)?
Weekly Report · 04/22 11:22
Laughing Water Capital Q1 2024 Letter
Seeking Alpha · 04/18 16:40
Weekly Report: what happened at WXXWY last week (0408-0412)?
Weekly Report · 04/15 11:14
Weekly Report: what happened at WXXWY last week (0401-0405)?
Weekly Report · 04/08 11:19
Weekly Report: what happened at WXXWY last week (0325-0329)?
Weekly Report · 04/01 11:16
Weekly Report: what happened at WXXWY last week (0318-0322)?
Weekly Report · 03/25 11:19
Week In Review: 3 Multinationals Plan Investments In Southeast Asia Facilities
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Novo Nordisk announced plans to invest $556 million to expand its Tianjin production facility. BeiGene was approved to market a new drug in the US.
Seeking Alpha · 03/24 11:15
Weekly Report: what happened at WXXWY last week (0311-0315)?
Weekly Report · 03/18 11:18
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
The Biotechnology Innovation Organization, a U.S. Industry lobbying group, has severed ties with Chinese biotech firm WuXi AppTec. BIO's decision comes in response to two bills targeting Chinese biotech firms circulating in Congress. The company's shares plummeted 13% on the Hong Kong and Shanghai exchanges.
Benzinga · 03/14 20:03
Biotech group backs anti-China bill; part ways with WuXi AppTec
Healthcare Biotech group backs anti-China bill; part ways with WuXi AppTec. The biotech industry's top lobbying group backs a proposed bill against a group of Chinese biopharma firms. The proposed legislation aims to restrict Chinese biotech companies from accessing federal funds.
Seeking Alpha · 03/14 11:20
Weekly Report: what happened at WXXWY last week (0304-0308)?
Weekly Report · 03/11 11:14
Weekly Report: what happened at WXXWY last week (0226-0301)?
Weekly Report · 03/04 11:17
Weekly Report: what happened at WXXWY last week (0219-0223)?
Weekly Report · 02/26 11:31
Hoping For Better Luck, HK Stocks Enter The Year Of The Dragon
Home Market Outlook Today's Market Hoping For Better Luck, HK Stocks Enter The Year Of The Dragon. In the lunar year of the rabbit, the benchmark Hang Seng Index fell a whopping 28.6%. The dragon is associated with good fortune, strength, and vigor in the Chinese calendar. Since the index was launched in 1969, the dragon has always risen in the dragon years.
Seeking Alpha · 02/22 07:49
Weekly Report: what happened at WXXWY last week (0212-0216)?
Weekly Report · 02/19 11:33
Weekly Report: what happened at WXXWY last week (0205-0209)?
Weekly Report · 02/12 11:22
More
Webull provides a variety of real-time WXXWY stock news. You can receive the latest news about Wuxi Biologics through multiple platforms. This information may help you make smarter investment decisions.
About WXXWY
WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing of biologics services. The Company's technology platforms include WuXiBody TM bispecific antibody technology platform and antibody drug conjugates (ADC) technology platform. It has brought in several new projects into its pipeline. The Company has a vaccine manufacturing facility and produces vaccines for customers to supply the global market. The Company conducts its businesses within the China market and to overseas markets, such as North America, Europe and other markets.